Evidence map›Paper›PMID 33897809›Full record

ArticleEvolutionary applications2021

Identifying key questions in the ecology and evolution of cancer.

Antoine M Dujon, Athena Aktipis, Catherine Alix-Panabières, Sarah R Amend, Amy M Boddy, Joel S Brown, Jean-Pascal Capp, James DeGregori, Paul Ewald, Robert Gatenby and 23 more

Abstract read
In one paragraph

Article in Evolutionary applications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Identifying Key Questions and Challenges in Microchimerism Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. EarlybioRxiv : the preprint server for biology · 2025
    Article
  10. Evolutionary Transcriptomics of Cancer Development.International journal of molecular sciences · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Antoine M DujonSchool of Life and Environmental Sciences Centre for Integrative Ecology Deakin University Waurn Ponds Vic. Australia.ORCID https://orcid.org/0000-0002-1579-9156
Athena AktipisBiodesign Institute Department of Psychology Arizona State University Tempe AZ USA.
Catherine Alix-PanabièresLaboratory of Rare Human Circulating Cells (LCCRH) University Medical Center of Montpellier Montpellier France.ORCID https://orcid.org/0000-0002-6401-2903
Sarah R AmendBrady Urological Institute The Johns Hopkins School of Medicine Baltimore MD USA.ORCID https://orcid.org/0000-0002-5606-1262
Amy M BoddyDepartment of Anthropology University of California Santa Barbara Santa Barbara CA USA.
Joel S BrownDepartment of Integrated Mathematics Moffitt Cancer Center Tampa FL USA.
Jean-Pascal CappToulouse Biotechnology Institute INSA/University of Toulouse CNRS INRAE Toulouse France.ORCID https://orcid.org/0000-0002-6470-079X
James DeGregoriDepartment of Biochemistry and Molecular Genetics Integrated Department of Immunology Department of Paediatrics Department of Medicine (Section of Hematology) University of Colorado School of Medicine Aurora CO USA.ORCID https://orcid.org/0000-0002-1287-1976
Paul EwaldDepartment of Biology University of Louisville Louisville KY USA.
Robert GatenbyDepartment of Radiology H. Lee Moffitt Cancer Center & Research Institute Tampa FL USA.ORCID https://orcid.org/0000-0002-1621-1510
Marco GerlingerTranslational Oncogenomics Lab The Institute of Cancer Research London UK.
Mathieu GiraudeauCREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD Montpellier France.ORCID https://orcid.org/0000-0001-8563-1810
Rodrigo K HamedeSchool of Natural Sciences University of Tasmania Hobart TAS Australia.ORCID https://orcid.org/0000-0003-1526-225X
Elsa HansenCenter for Infectious Disease Dynamics, Biology Department Pennsylvania State University University Park PA USA.ORCID https://orcid.org/0000-0003-1874-529X
Irina KarevaMathematical and Computational Sciences Center School of Human Evolution and Social Change Arizona State University Tempe AZ USA.
Carlo C MaleyArizona Cancer Evolution Center Biodesign Institute and School of Life Sciences Arizona State University Tempe AZ USA.ORCID https://orcid.org/0000-0002-0745-7076
Andriy MarusykDepartment of Cancer Physiology H Lee Moffitt Cancer Centre and Research Institute Tampa FL USA.
Nicholas McGranahanTranslational Cancer Therapeutics Laboratory The Francis Crick Institute London UK.ORCID https://orcid.org/0000-0001-9537-4045
Michael J MetzgerPacific Northwest Research Institute Seattle WA USA.
Aurora M NedelcuDepartment of Biology University of New Brunswick Fredericton NB Canada.ORCID https://orcid.org/0000-0002-7517-2419
Robert NobleDepartment of Biosystems Science and Engineering ETH Zurich Basel Switzerland.ORCID https://orcid.org/0000-0002-8057-4252
Leonard NunneyDepartment of Evolution, Ecology, and Organismal Biology University of California Riverside Riverside CA USA.ORCID https://orcid.org/0000-0002-4315-3694
Kenneth J PientaBrady Urological Institute The Johns Hopkins School of Medicine Baltimore MD USA.
Kornelia PolyakDepartment of Medical Oncology Dana-Farber Cancer Institute Boston MA USA.
Pascal PujolCREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD Montpellier France.
Andrew F ReadCenter for Infectious Disease Dynamics Huck Institutes of the Life Sciences Departments of Biology and Entomology Pennsylvania State University University Park PA USA.
Benjamin RocheCREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD Montpellier France.
Susanne SebensInstitute for Experimental Cancer Research Kiel University and University Hospital Schleswig-Holstein Kiel Germany.
Eric SolaryINSERM U1287 Gustave Roussy Villejuif France.
Kateřina StaňkováDepartment of Data Science and Knowledge Engineering Maastricht University Maastricht The Netherlands.
Holly Swain EwaldDepartment of Biology University of Louisville Louisville KY USA.
Frédéric ThomasCREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD Montpellier France.ORCID https://orcid.org/0000-0003-2238-1978
Beata UjvariSchool of Life and Environmental Sciences Centre for Integrative Ecology Deakin University Waurn Ponds Vic. Australia.ORCID https://orcid.org/0000-0003-2391-2988

Funding

The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
Determining how aging-associated changes in the microenvironment contribute to leukemogenesisR01AG067584 · NIA · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V · 2019 to 2022
$1.7M
Evolution of transmissible cancers and genetics of host resistanceK22CA226047 · NCI · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI METZGER, MICHAEL JEFFREY · 2018 to 2020
$579k
BLRD VA I01 BX004495NCI NIH HHS K22 CA226047NCI NIH HHS U54 CA217376NIA NIH HHS R01 AG067584
6 · The paper itself

Abstract

The application of evolutionary and ecological principles to cancer prevention and treatment, as well as recognizing cancer as a selection force in nature, has gained impetus over the last 50 years. Following the initial theoretical approaches that combined knowledge from interdisciplinary fields, it became clear that using the eco-evolutionary framework is of key importance to understand cancer. We are now at a pivotal point where accumulating evidence starts to steer the future directions of the discipline and allows us to underpin the key challenges that remain to be addressed. Here, we aim to assess current advancements in the field and to suggest future directions for research. First, we summarize cancer research areas that, so far, have assimilated ecological and evolutionary principles into their approaches and illustrate their key importance. Then, we assembled 33 experts and identified 84 key questions, organized around nine major themes, to pave the foundations for research to come. We highlight the urgent need for broadening the portfolio of research directions to stimulate novel approaches at the interface of oncology and ecological and evolutionary sciences. We conclude that progressive and efficient cross-disciplinary collaborations that draw on the expertise of the fields of ecology, evolution and cancer are essential in order to efficiently address current and future questions about cancer.

Indexed as

cancer therapycontemporary evolutionevolutionary medicinegeneticsneoplasmspecies interactions

Identifiers

PMID33897809
PMCPMC8061275

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.